Literature DB >> 24001409

Clinical features of hereditary angioedema in Chinese patients: new findings and differences from other populations.

Ying-Yang Xu1, Ying Jiang, Yu-Xiang Zhi, Jia Yin, Liang-Lu Wang, Li-Ping Wen, Jian-Qing Gu, Kai Guan, Hong-Yu Zhang.   

Abstract

BACKGROUND: Hereditary angioedema (HAE), caused by C1 inhibitor deficiency, is characterized by recurrent subcutaneous or submucosal swelling. Because it is rare, data on clinical features, especially in Chinese patients, are not comprehensive.
OBJECTIVE: Our aim was to identify the characteristics of HAE in a Chinese population and enhance clinical knowledge of this disease.
METHODS: One hundred and fifty-eight symptomatic patients were studied retrospectively. Data were obtained from medical records. Statistical analyses were performed using statistical software package: R version 2.14.0.
RESULTS: The majority of patients first experienced attacks during the second (42%) and third (32%) decades: the mean onset of symptoms was at the age of 21.25 years. The percentage of patients having experienced a swelling at least once for the following sites were: extremities (83.54%); pharyngolarynx (58.86%); face (55.06%); gastrointestinal tract (34.17%); trunk (18.35%) and genitalia (15.33%). Rare manifestations included melaena, swollen gastric mucosa inverting into the oesophagus, pleural effusion, dysuria and syncope. For patients who first experienced swelling in pre-adolescence, 41.67% noted intensified attack rates when they entered puberty. In pregnancy, 61.70% did not note a change in HAE attack frequency.
CONCLUSION: Compared with previous studies, the mean age of symptom onset is older. The frequencies of abdominal attacks occurring in patients on the Chinese Mainland, as well as in Taiwan and Japan, appears much lower than in western countries. Ethnic or environmental differences may contribute to this finding. Melaena and gastric mucosa inverting into the oesophagus secondary to edema are first reported here.

Entities:  

Mesh:

Year:  2013        PMID: 24001409     DOI: 10.1684/ejd.2013.2105

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  10 in total

1.  Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema.

Authors:  Yang Cao; Shuang Liu; Yuxiang Zhi
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

2.  Mutation update of SERPING1 related to hereditary angioedema in the Chinese population.

Authors:  Xue Wang; Shubin Lei; Yingyang Xu; Shuang Liu; Yuxiang Zhi
Journal:  Hereditas       Date:  2022-07-11       Impact factor: 2.595

Review 3.  Diagnosis and screening of patients with hereditary angioedema in primary care.

Authors:  Maria Paula Henao; Jennifer L Kraschnewski; Theodore Kelbel; Timothy J Craig
Journal:  Ther Clin Risk Manag       Date:  2016-05-02       Impact factor: 2.423

4.  Health-related quality of life and its risk factors in Chinese hereditary angioedema patients.

Authors:  Shuang Liu; Xue Wang; Yingyang Xu; Qun Xu; Yuxiang Zhi
Journal:  Orphanet J Rare Dis       Date:  2019-08-08       Impact factor: 4.123

5.  The prevalence of hereditary angioedema in a Chinese cohort with decreased complement 4 levels.

Authors:  Qi Cui; Qingxiu Xu; Yaqi Yang; Wenjing Li; Nan Huang; Hao Chen; Dongxia Ma; Shuchen Zhang; Lin Yang; Rongfei Zhu
Journal:  World Allergy Organ J       Date:  2021-12-18       Impact factor: 4.084

6.  Clinical Characteristics and Management of Angioedema Attacks in Polish Adult Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency.

Authors:  Katarzyna Piotrowicz-Wójcik; Małgorzata Bulanda; Aldona Juchacz; Joanna Jamróz-Brzeska; Jacek Gocki; Krzysztof Kuziemski; Robert Pawłowicz; Grzegorz Porebski
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

7.  Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain.

Authors:  Kyle Staller; Anthony Lembo; Aleena Banerji; Jonathan A Bernstein; Eric D Shah; Marc A Riedl
Journal:  J Clin Gastroenterol       Date:  2022-08-15       Impact factor: 3.174

8.  Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies.

Authors:  Timothy J Craig; Rafael H Zaragoza-Urdaz; H Henry Li; Ming Yu; Hong Ren; Salomé Juethner; John Anderson
Journal:  Allergy Asthma Clin Immunol       Date:  2022-09-24       Impact factor: 3.373

9.  The natural course of hereditary angioedema in a Chinese cohort.

Authors:  Yang Cao; Shuang Liu; Yuxiang Zhi
Journal:  Orphanet J Rare Dis       Date:  2020-09-22       Impact factor: 4.123

10.  Clinical and genetic features of hereditary angioedema with and without C1-inhibitor (C1-INH) deficiency in Japan.

Authors:  Chinami Hashimura; Chikako Kiyohara; Jun-Ichi Fukushi; Tomoya Hirose; Isao Ohsawa; Tomoko Tahira; Takahiko Horiuchi
Journal:  Allergy       Date:  2021-08-12       Impact factor: 14.710

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.